Product Description

Liofilchem AD Fosfomycin panel comprises 12 wells, with antibiotic incorporated into an agar medium in 11 two-fold dilutions (0.25-256 μg/mL)

With an increase in the numbers of bacterial isolates resistant to first-line antibiotics, there has been a revival in the use of older drugs including fosfomycin. Although several commercial tests based on different techniques have been developed, Agar Dilution (AD) is considered the best method for performing Fosfomycin susceptibility testing so far.

The new AD Fosfomycin 0.25-256 is the first and only (international patent pending) ready-to-use commercially available kit for performing the agar dilution antimicrobial susceptibility testing, in compliance with the CLSI and EUCAST standards, with 3 months shelf life at present.

The AD Fosfomycin panel comprises 12 wells, containing the antibiotic incorporated into an agar medium in different concentrations, i.e. 11 two-fold dilutions (0.25-256 μg/mL).

The AD Fosfomycin 0.25-256 panel is the first of a series of agar dilution panels, which will be available as both standard and custom versions, in terms of antibiotics and concentrations.

Product Details

Manufacturer Liofilchem
Unit 6 panels
Code 77061
For sale in GBR NIR
Launch Diagnostics is a licensed reseller and distributor of Fosfomycin Agar Dilution panel

Launch Diagnostics is one of the major independent distributors in the U.K, providing high quality diagnostic reagents and instrumentation from world leading manufacturer’s to the Health Services of the United Kingdom, France, Belgium, Netherlands, Luxemburg and North Africa and to the Republic of Ireland through ACCUSAY Diagnostics.

Offering a large portfolio of diagnostic kits, laboratory instrumentation and services, our product range has expanded over the years to include a comprehensive range of EIA, single test devices, serology products, molecular assays and instrumentation.

MicrobiologyAntimicrobial Susceptibility / MICAntimicrobial susceptibilty